U.S. Paper and Forestry Products Stock News

Southern Copper recently reported record 2025 net sales, adjusted EBITDA, and net income, supported by higher copper and by‑product output, improved metal prices, and confirmed progress on major projects such as Tia Maria in Peru, alongside quarterly cash and stock dividends to shareholders. An interesting angle is the simultaneous rise in short interest to 10.94% of float, which contrasts with strong earnings beats and richer capital returns, highlighting a sharp divide in investor...

AI shock and sector selloff set the scene Arthur J. Gallagher (AJG) has been caught up in a broader insurance broker selloff after OpenAI approved the first AI insurance application on ChatGPT, raising questions about how technology could affect traditional intermediation. See our latest analysis for Arthur J. Gallagher. The recent AI shock has landed on a share price that was already under pressure, with a 7 day share price return of 13.7% decline and a 30 day share price return of 19.4%...

Wynn Resorts, Limited recently reported fourth-quarter and full-year 2025 results, with operating revenue rising to US$1.87 billion in the quarter while net income declined to US$100.03 million, and its Board maintained a cash dividend of US$0.25 per share payable on March 4, 2026 to stockholders of record on February 23, 2026. The earnings highlighted a contrast between revenue growth led by Macau and softer profitability in Las Vegas and Encore Boston Harbor, as higher costs,...

In February 2026, Teradyne, Inc. reported fourth-quarter 2025 sales of US$1,083.34 million and net income of US$257.22 million, and issued first-quarter 2026 guidance for revenue of US$1,150 million to US$1,250 million with GAAP diluted EPS of US$1.82 to US$2.19. The combination of stronger year-on-year quarterly results and relatively firm earnings guidance offers fresh insight into how Teradyne’s operations are tracking against earlier expectations for growth in test and automation...

Why Victory Capital Holdings (VCTR) is on investors’ radar Victory Capital Holdings (VCTR) has drawn attention after a period of steady share performance, with returns over the past month and past 3 months giving investors fresh context for its current valuation. See our latest analysis for Victory Capital Holdings. At a share price of US$74.74, Victory Capital’s recent 10.12% 1 month share price return and 20.98% 3 month share price return contrast with its 11.31% 1 year total shareholder...

Antero Resources (AR) has attracted renewed attention after recent trading produced a 7.4% return over the past month, compared with a 12.8% decline over the past year for shareholders. See our latest analysis for Antero Resources. That recent 7.4% 1 month share price return, alongside a 3.3% gain over 90 days and a 1.6% year to date rise to US$34.76, contrasts with a 12.8% 1 year total shareholder return decline and much stronger 3 and 5 year total shareholder returns. This suggests shorter...

GEO Group (GEO) is back in focus after its biggest year of new and expanded government contracts, combined with a CEO transition that brings founder Dr. George Zoley back into the top job. See our latest analysis for GEO Group. The recent contract wins and CEO transition come after a mixed run in the share price, with a 1-day share price return of 5.49%, a 30-day share price return decline of 19.22%, a 1-year total shareholder return decline of 47.87%, and positive 3-year and 5-year total...

Why TechnipFMC is back on traders’ radar TechnipFMC (FTI) has jumped into focus after recent share buyback activity coincided with strong trading volume, tightening the spotlight on how offshore and subsea project demand could influence margins and short term price action. See our latest analysis for TechnipFMC. At a share price of $61.36, TechnipFMC has seen strong recent momentum, with a 30 day share price return of 17.64% and a 1 year total shareholder return above 100%. Traders appear to...

In February 2026, Alnylam Pharmaceuticals reported its fourth-quarter and full-year 2025 results, showing revenue rising to US$1.10 billion for the quarter and US$3.71 billion for the year, with a shift from prior losses to net income of US$111.54 million in Q4 and US$313.75 million for 2025. The company’s first full year of GAAP profitability was largely powered by Amvuttra’s expanded use in transthyretin amyloid cardiomyopathy and was accompanied by a US$2.26 billion shelf registration for...

In recent filings, Trump Media & Technology Group’s affiliate Truth Social Funds sought SEC approval for two crypto ETFs tied to Bitcoin, Ether, and Cronos that incorporate staking rewards, offered in partnership with Crypto.com and advised by Yorkville America Equities. This move extends Trump Media’s business beyond social media into crypto-linked investment vehicles, deepening its relationship with Crypto.com and broadening its exposure to digital-asset infrastructure. We’ll now examine...

Earlier this month, Whirlpool Corporation’s brands used the 2026 Kitchen and Bath Industry Show to unveil a wave of advanced smart appliances, including KitchenAid’s AI-enabled ovens and refrigerators, Whirlpool’s UV Clean laundry tower and nugget-ice refrigerators, and a Spearmint-themed Color of the Year range. This cluster of launches underlines Whirlpool’s push to differentiate through design and embedded intelligence, signaling a focus on higher-value, premium home appliances across its...

If you are wondering whether Coca-Cola is fairly priced at around US$78.68 or if the market is asking too much for such a well known brand, you are not alone. The stock has had a mixed short term patch, with a 0.4% decline over the last 7 days, but returns of 11.7% over 30 days, 13.8% year to date, 17.6% over 1 year, 43.2% over 3 years and 82.5% over 5 years give useful context for any valuation check. Recent coverage has continued to focus on Coca-Cola's role as a global consumer staples...

Dividend strain moves to the forefront for MFA Financial (MFA) A recent review of MFA Financial’s dividend shows payouts at 180% of Q3 2025 earnings, with operating cash flow covering only 0.27 times dividends over the first nine months of 2025. See our latest analysis for MFA Financial. The recent dividend concerns sit alongside mixed price action, with a 90 day share price return of 8.68% and a 1 year total shareholder return of 7.81%. However, the 30 day share price return shows a 2.08%...

If you are wondering whether Sprouts Farmers Market at around US$68.96 is starting to look expensive or still offers value, this article will walk through what the numbers are actually saying. The stock has been volatile recently, with a 2.4% gain over the last 7 days, a 12.3% decline over 30 days, and a 14.5% decline year to date, after a 61.1% decline over the last year, even though the 3 year and 5 year returns sit at 108.7% and 215.2% respectively. These swings have kept Sprouts Farmers...

If you are wondering whether Supernus Pharmaceuticals at around US$50.84 is still offering value or starting to look fully priced, you are in the right place. The stock has seen mixed short term moves, with a 1.6% decline over the last 7 days, a 1.7% gain over 30 days, and a 2.8% return year to date, while the 1 year return sits at 30.0% and the 5 year return at 71.7%. Recent attention on Supernus Pharmaceuticals has focused on how the market is reassessing specialty pharma names and their...

Revolve Group (NYSE:RVLV) has opened a flagship store at The Grove in Los Angeles. The new location brings the REVOLVE and FWRD brands into a single, high profile physical space. This marks an expansion of the company’s offline footprint beyond its core online model. Revolve Group is stepping further into brick and mortar with a flagship store at The Grove, a move that puts its online native brands in front of heavy foot traffic. The stock closed at $25.09, with returns over the past year...

In recent weeks, Cavco Industries announced that its CEO bought 1,000 shares for about US$495,000 while the company repurchased roughly US$44,000,000 of its stock, following a post-earnings pullback earlier this year. This combination of insider buying and corporate buybacks has been interpreted by many investors as a clear signal of management’s conviction in the business. We’ll now examine how this renewed insider confidence, highlighted by the CEO’s recent purchase, may influence Cavco’s...

LiveRamp Holdings (NYSE:RAMP) expanded and extended its share repurchase program by $200 million. The authorization now runs through 2027, providing a longer window for buybacks. The company cited confidence in its balance sheet, cash generation, and AI driven opportunities as key factors. LiveRamp runs a data collaboration platform that helps brands and partners connect and activate customer data across channels while aiming to respect privacy rules. The latest buyback move comes as demand...

Preferred dividend event and what it means for Wells Fargo stock Wells Fargo (WFC) has just declared quarterly dividends on six series of preferred stock, a capital allocation move that sits alongside its recent funding programs and mixed shelf registration. For you as a common shareholder, these preferred dividends do not change the common dividend directly, but they do shape how Wells Fargo structures its overall capital stack and ongoing funding costs. See our latest analysis for Wells...

Sector jitters hit Moody's ahead of earnings Moody's (MCO) shares dropped 5% after S&P Global issued disappointing guidance and missed 2026 estimates, prompting investors to reassess financial data providers just as Moody's prepares to report quarterly earnings. See our latest analysis for Moody's. At a share price of $426.44, Moody's has seen a 1 month share price return decline of 20.87% and a 1 year total shareholder return decline of 17.82%. However, the 3 and 5 year total shareholder...

Vertex Pharmaceuticals (NasdaqGS:VRTX) has entered into an agreement with WuXi Biologics to develop a trispecific T-cell engager for B-cell mediated autoimmune diseases. The deal gives Vertex exclusive rights to develop and commercialize this preclinical therapy, expanding its pipeline beyond cystic fibrosis and gene therapies. Vertex, trading at $491.47, has seen its share price move by 2.8% over the past week and 11.4% over the past month, with a 3-year return of 67.4% and a 5-year return...

EnerSys recently reported its third-quarter and nine-month fiscal 2026 results, showing higher revenue but lower net income year over year, while also declaring a US$0.2625 per-share quarterly dividend payable on March 27, 2026, to shareholders of record on March 13, 2026. Alongside new fourth-quarter net sales guidance of US$960 million to US$1.00 billion and completion of a buyback tranche covering 1.91% of its shares for US$90.12 million, EnerSys is signaling how it currently balances...

Plains GP Holdings (PAGP) has drawn investor attention recently after a steady run in its unit price, with the stock closing at $21.59 as of the latest trading session. See our latest analysis for Plains GP Holdings. Beyond the latest close at $21.59, Plains GP Holdings has shown building momentum, with recent 1 week, 1 month and 3 month share price returns of 4.25%, 5.06% and 21.57% respectively, alongside a 5 year total shareholder return of 265.75%. If this midstream move has your...

In early February 2026, Twist Bioscience Corporation launched the Twist TrueAmp Library Preparation Kit and the Twist PCR-Free WGS Library Preparation Kit, designed to improve next-generation sequencing workflows for low-input and challenging samples in clinical research. By combining in-house engineered enzymes with PCR-free whole-genome sequencing options, Twist is aiming to improve data quality and scalability for researchers across applications like rare disease and cancer. We will now...